Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suprachoroidal Triamcinolone Acetonide Injection in Two Chorioretinal Diseases: One Year Results

NCT05337332 is registered in ClinicalTrials.gov with Benha University as lead sponsor.

NCT NCT05337332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05337332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suprachoroidal Triamcinolone Acetonide Injection in Two Chorioretinal Diseases: One Year Results
Lead sponsor
Benha University
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 14, 2022
Completion date
June 1, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy, cystoid macular edema, irvine-gass syndrome, pars planitis